We are live on ! Find out more
PI

Pharmstandard International Portfolio holdings

AUM $29M
1-Year Est. Return 3.25%
This Fund
S&P 500
This Quarter Est. Return
-2.02%
1 Year Est. Return
+3.25%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
–
Cap. Flow
+$117M
Cap. Flow %
100.79%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ARGS
Argos Therapeutics, Inc.
ARGS
+$61.9M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$21.9M
3
TARA icon
Protara Therapeutics
TARA
+$9.21M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 76.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGS
1
DELISTED
Argos Therapeutics, Inc.
ARGS
$64.9M 55.88%
+662,114
New +$61.9M
ARGS
2
CALL
DELISTED
Argos Therapeutics, Inc.
ARGS
$27.4M 23.59%
+256,030
New +$24M
PTGX icon
3
Protagonist Therapeutics
PTGX
$8.71B
$21.6M 18.63%
+983,570
New +$21.9M
TARA icon
4
Protara Therapeutics
TARA
$229M
$2.21M 1.91%
+29,134
New +$9.21M

Similar funds

IP
Ironsides Partners Boston, Massachusetts $27.7M AUM 1.11% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
MC
Marcus Capital Northbrook, Illinois $34.3M AUM 30.44% 1-Year Est. Return
RIA
Rocaton Investment Advisors Norwalk, Connecticut $36.6M AUM 10.31% 1-Year Est. Return
FC
Flaherty & Crumrine Pasadena, California $19.8M AUM 3.53% 1-Year Est. Return
WFC
West Face Capital Toronto, Ontario, Canada $16.6M AUM 18.79% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
DCM
Dearborn Capital Management Chicago, Illinois $41.6M AUM 2.79% 1-Year Est. Return

Pharmstandard International's Q4 2016 Portfolio in Review

Q4 2016 is the first quarter with a 13F filing on record for Pharmstandard International, which disclosed 4 positions worth $116M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Argos Therapeutics, Inc.: 662,114 shares worth $64.9M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets.

  • Pharmstandard International's largest Q4 2016 buy was Argos Therapeutics, Inc.: 662,114 shares worth $64.9M.
  • Pharmstandard International's ten largest holdings make up 100% of its $116M portfolio in Q4 2016.
  • Pharmstandard International disclosed 4 positions in Q4 2016, its first 13F filing on record.

Based on Pharmstandard International's 13F filing for Q4 2016, filed 14 Feb 2017.